• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ross retires from Imatron

Article

Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a

Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a library.

The position of president was created in 1998 as an enticement for Ross to lead the company. The agreement then was for Ross to stay just two years, long enough to redirect Imatron toward more profitable activities. He remained longer than initially planned. But for the last six weeks Ross has been on vacation. His retirement was not announced until Ross was satisfied that the company was functioning well without him.

CEO S. Lewis Meyer has taken over the helm.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.